Shanghai Aohua Photoelectricity Endoscope (688212.SH) issues a profit warning, expecting a net profit of 15.73 million to 23.38 million yuan for the year 2024, a year-on-year decrease of 59.59% to 72.81%.
Australia China Endoscope (688212.SH) issued a notice, the company expects to achieve attributable to owners of the parent company in 2024...
Shanghai Aohua Photoelectric Endoscope (688212.SH) announced that the company expects to achieve a net profit attributable to the owner of the parent company of 15.73 million to 23.38 million in 2024. Compared with the same period last year, it will decrease by 34.4744 million to 42.1244 million, a year-on-year decrease of 59.59% to 72.81%.
Related Articles

Hubei Radio & Television Information Network(000665.SZ) received a warning letter from the Hubei Securities Regulatory Bureau.

REPT BATTERO (00666): Searching for a new turning point for profitability at the bottom of the cycle.

Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.
Hubei Radio & Television Information Network(000665.SZ) received a warning letter from the Hubei Securities Regulatory Bureau.

REPT BATTERO (00666): Searching for a new turning point for profitability at the bottom of the cycle.

Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025